IMPLANT SITE HYPERSENSITIVITY

This adverse event was reported 111 times

These drugs are most commonly taken by patients reporting IMPLANT SITE HYPERSENSITIVITY:

# Drug Count
0 ETONOGESTREL 72
1 CLONAZEPAM 6
2 AMLODIPINE BESYLATE 5
3 CARVEDILOL 5
4 IBUPFROFEN 5
5 IBUPROFEN 5
6 IBUPROFEN 200 MG 5
7 IBUPROFEN 200MG 5
8 IBUPROFEN CAPSULE 5
9 IBUPROFEN CAPSULES 200 MG 5
See all common drugs associated with IMPLANT SITE HYPERSENSITIVITY

IMPLANT SITE HYPERSENSITIVITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 AFAMELANOTIDE 2 0.0952
1 ETONOGESTREL 72 0.0013
2 AMPICILLIN AND SULBACTAM 1 0.0011
3 TAZAROTENE 1 0.0008
4 CLONIDINE HYDROCHLORIDE 3 0.0005
5 VANCOMYCIN HYDROCHLORIDE 4 0.0005
6 LEBRIKIZUMAB-LBKZ 1 0.0004
7 AMPICILLIN SODIUM AND SULBACTAM SODIUM 1 0.0004
8 BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0003
9 1168 BURN SPRAY 1 0.0003
See all drugs enriched for association with IMPLANT SITE HYPERSENSITIVITY